Concepedia

David Hoffmann

DH

10

Publications

809

Citations

10

H-Index

1981

Active since

Affiliations

Institute of Molecular Biotechnology(Current)

University of British Columbia

Vienna Biocenter

Austrian Academy of Sciences

Research Institute of Molecular Pathology

David Hoffmann is an author at Institute of Molecular Biotechnology specializing in medicine, immunology, and cell biology.

Top concepts

MedicineImmunologyCell BiologyImmunotherapyAutoimmunityCell SignalingAutoimmune DiseaseSignal TransductionTumor MicroenvironmentAllergy

Publications per year

1981–2021

10

Publications

10

The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

Shane J. F. Cronin, Corey R. Seehus, Adelheid Weidinger et al. · Nature · 2018 · 274 citations · Full text

Cancer Immunosurveillance, Autoimmune Disease, T-regulatory Cell +8

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

Lisa Haas, Anais Elewaut, Camille L. Gérard et al. · Nature Cancer · 2021 · 190 citations · Full text

Therapy Confers, Tumor Immunology, Immune-evasive Tumor Microenvironment +10

Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy

Iris Uribesalgo, David Hoffmann, Yin Zhang et al. · EMBO Molecular Medicine · 2019 · 105 citations · Full text

Identification of lectin receptors for conserved SARS‐CoV‐2 glycosylation sites

David Hoffmann, Stefan Mereiter, Yoo Jin Oh et al. · The EMBO Journal · 2021 · 76 citations · Full text

Megakaryocytes use in vivo podosome‐like structures working collectively to penetrate the endothelial barrier of bone marrow sinusoids

Anita Eckly, Cyril Scandola, Antoine Oprescu et al. · Journal of Thrombosis and Haemostasis · 2020 · 55 citations

Regenerative Medicine, Bone Marrow Sinusoids, Developmental Biology +13

Rows per page

1–5 of 10